Literature DB >> 15960235

Assessment of neuroAIDS in Africa.

Kevin Robertson1, Kathy Kopnisky, Jens Mielke, Kuku Appiah, Colin Hall, Richard Price, Johnstone Kumwenda, Cecelia Kanyama, Farida Amod, Christina Marra, Terrie Taylor, Umesh Lalloo, Jennifer Jelsma, Penny Holding, Michael Boivin, Gretchen Birbeck, Noelene Nakasujja, Ian Sanne, Thomas D Parsons, Amanda Parente, Karen Tucker.   

Abstract

Mesh：

Year:  2005        PMID： 15960235

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


× No keyword cloud information.
  6 in total

1.  Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western Kenya.

Authors:  Deanna Cettomai; Judith Kwasa; Gretchen L Birbeck; Richard W Price; Elizabeth A Bukusi; Ana-Claire Meyer
Journal:  J Neurol Sci       Date:  2011-06-11       Impact factor: 3.181

2.  HIV-Associated Neurocognitive Disorder (HAND) and the Prospect of Brain-Penetrating Protease Inhibitors for Antiretroviral Treatment.

Authors:  Arun K Ghosh; Anindya Sarkar; Hiroaki Mitsuya
Journal:  Med Res Arch       Date:  2017-04-15

3.  Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.

Authors:  Walter Royal; Mariana Cherner; Jean Carr; Abdulrazaq G Habib; Abimbola Akomolafe; Alashl'e Abimiku; Manhattan Charurat; John Farley; Akinwande Oluyemisi; Ibrahim Mamadu; Joyce Johnson; Ronald Ellis; J Allen McCutchan; J Allen McCutchen; Igor Grant; William A Blattner
Journal:  J Neurovirol       Date:  2012-04-18       Impact factor: 2.643

Review 4.  Antiretroviral therapy and central nervous system HIV type 1 infection.

Authors:  Richard W Price; Serena Spudich
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

5.  Impact of long-term treatment with neurotoxic dideoxynucleoside antiretrovirals: implications for clinical care in resource-limited settings.

Authors:  C F Hung; S A Gibson; S L Letendre; J T Lonergan; J A Marquie-Beck; F Vaida; R J Ellis
Journal:  HIV Med       Date:  2008-07-21       Impact factor: 3.180

Review 6.  Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers.

Authors:  Magnus Gisslen; Lars Hagberg; Lars Rosengren; Bruce J Brew; Paola Cinque; Serena Spudich; Richard W Price
Journal:  J Neuroimmune Pharmacol       Date:  2006-09-12       Impact factor: 4.147
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.